title: Whole-eye versus lens-sparing megavoltage therapy for retinoblastoma.
authors.affiliation: Department of Ophthalmology, Saint Bartholomew's Hospital, London, UK.
authors.forename: J L
authors.initials: JL
authors.lastname: Hungerford
authors.forename: N M
authors.initials: NM
authors.lastname: Toma
authors.forename: P N
authors.initials: PN
authors.lastname: Plowman
authors.forename: D
authors.initials: D
authors.lastname: Doughty
authors.forename: J E
authors.initials: JE
authors.lastname: Kingston
mesh_terms: D002386:Cataract / Q000209:etiology; D002648:Child; D003261:Contact Lenses; D017679:Cryotherapy; D004307:Dose-Response Relationship, Radiation; D005123:Eye / Q000528:radiation effects*; D005134:Eye Neoplasms / Q000532:radiotherapy*; D005500:Follow-Up Studies; D006801:Humans; D007908:Lens, Crystalline / Q000528:radiation effects; D009364:Neoplasm Recurrence, Local; D011832:Radiation Injuries / Q000209:etiology; D011882:Radiotherapy, High-Energy / Q000009:adverse effects / Q000379:methods*; D015203:Reproducibility of Results; D012175:Retinoblastoma / Q000532:radiotherapy*; D012189:Retrospective Studies; D016879:Salvage Therapy; D013997:Time Factors; D016896:Treatment Outcome